Delva A, Koole M, Serdons K, Bormans G, Liu L, Bard J
Eur J Nucl Med Mol Imaging. 2022; 50(1):48-60.
PMID: 36001116
DOI: 10.1007/s00259-022-05945-z.
Kim M, Juarez Anaya F, Manly L, Lee J, Hong J, Shrestha S
J Nucl Med. 2022; 64(1):159-164.
PMID: 35798558
PMC: 9841251.
DOI: 10.2967/jnumed.122.264061.
Biegon A, Cohen S, Franceschi D
J Pers Med. 2022; 12(5).
PMID: 35629147
PMC: 9146871.
DOI: 10.3390/jpm12050725.
Arakawa R, Takano A, Nag S, Jia Z, Amini N, Maresca K
EJNMMI Res. 2022; 12(1):13.
PMID: 35244788
PMC: 8897535.
DOI: 10.1186/s13550-022-00882-2.
Zanotti-Fregonara P
Semin Nucl Med. 2022; 52(2):140-148.
PMID: 35067360
PMC: 8923960.
DOI: 10.1053/j.semnuclmed.2021.12.007.
Human biodistribution and dosimetry of [C]-UCB-J, a PET radiotracer for imaging synaptic density.
Cawthorne C, Maguire P, Mercier J, Sciberras D, Serdons K, Bormans G
EJNMMI Phys. 2021; 8(1):37.
PMID: 33891195
PMC: 8065069.
DOI: 10.1186/s40658-021-00384-5.
Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [C]K-2, in healthy human subjects.
Hatano M, Miyazaki T, Ishiwata Y, Nakajima W, Arisawa T, Kuroki Y
Sci Rep. 2021; 11(1):1598.
PMID: 33452361
PMC: 7810729.
DOI: 10.1038/s41598-021-81002-3.
Human biodistribution and radiation dosimetry of the 5-HT receptor agonist Cimbi-36 labeled with carbon-11 in two positions.
Johansen A, Holm S, Dall B, Keller S, Kristensen J, Knudsen G
EJNMMI Res. 2019; 9(1):71.
PMID: 31367837
PMC: 6669221.
DOI: 10.1186/s13550-019-0527-4.
[C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers.
Van Weehaeghe D, Koole M, Schmidt M, Deman S, Jacobs A, Souche E
Eur J Nucl Med Mol Imaging. 2019; 46(10):2051-2064.
PMID: 31243495
DOI: 10.1007/s00259-019-04369-6.
Characterization of [C]PXT012253 as a PET Radioligand for mGlu Allosteric Modulators in Nonhuman Primates.
Takano A, Nag S, Jia Z, Jahan M, Forsberg A, Arakawa R
Mol Imaging Biol. 2018; 21(3):500-508.
PMID: 30066121
DOI: 10.1007/s11307-018-1257-0.
Synthesis and preliminary PET imaging of C and F isotopologues of the ROS1/ALK inhibitor lorlatinib.
Collier T, Normandin M, Stephenson N, Livni E, Liang S, Wooten D
Nat Commun. 2017; 8:15761.
PMID: 28594000
PMC: 5472746.
DOI: 10.1038/ncomms15761.
11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.
Ikawa M, Lohith T, Shrestha S, Telu S, Zoghbi S, Castellano S
J Nucl Med. 2016; 58(2):320-325.
PMID: 27856631
PMC: 5288742.
DOI: 10.2967/jnumed.116.178996.
Radiation dosimetry of the αβ nicotinic receptor ligand (+)-[F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results.
Kranz M, Sattler B, Tiepolt S, Wilke S, Deuther-Conrad W, Donat C
EJNMMI Phys. 2016; 3(1):25.
PMID: 27770429
PMC: 5074934.
DOI: 10.1186/s40658-016-0160-5.
Tactics for preclinical validation of receptor-binding radiotracers.
Lever S, Fan K, Lever J
Nucl Med Biol. 2016; 44:4-30.
PMID: 27755986
PMC: 5161541.
DOI: 10.1016/j.nucmedbio.2016.08.015.
Comparison of two PET radioligands, [C]FPEB and [C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain.
Lohith T, Tsujikawa T, Simeon F, Veronese M, Zoghbi S, Lyoo C
J Cereb Blood Flow Metab. 2016; 37(7):2458-2470.
PMID: 27629098
PMC: 5531344.
DOI: 10.1177/0271678X16668891.
Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors.
Kranz M, Sattler B, Wust N, Deuther-Conrad W, Patt M, Meyer P
Molecules. 2016; 21(9).
PMID: 27598110
PMC: 6273209.
DOI: 10.3390/molecules21091164.
Radiation Dosimetry of a Novel Adenosine A Receptor Radioligand [C]Preladenant Based on PET/CT Imaging and Ex Vivo Biodistribution in Rats.
Zhou X, Elsinga P, Khanapur S, Dierckx R, de Vries E, de Jong J
Mol Imaging Biol. 2016; 19(2):289-297.
PMID: 27539309
PMC: 5336543.
DOI: 10.1007/s11307-016-0992-3.
Guidelines to PET measurements of the target occupancy in the brain for drug development.
Takano A, Varrone A, Gulyas B, Salvadori P, Gee A, Windhorst A
Eur J Nucl Med Mol Imaging. 2016; 43(12):2255-2262.
PMID: 27514528
PMC: 5047931.
DOI: 10.1007/s00259-016-3476-4.
[(11)C]TASP457, a novel PET ligand for histamine H3 receptors in human brain.
Kimura Y, Seki C, Ikoma Y, Ichise M, Kawamura K, Takahata K
Eur J Nucl Med Mol Imaging. 2016; 43(9):1653-63.
PMID: 26902370
DOI: 10.1007/s00259-016-3332-6.
Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
DeLorenzo C, Sovago J, Gardus J, Xu J, Yang J, Behrje R
Transl Psychiatry. 2015; 5:e693.
PMID: 26645628
PMC: 5068588.
DOI: 10.1038/tp.2015.189.